Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The hazards of chrysotile asbestos: a critical review.

Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J.

Ind Health. 1999 Jul;37(3):271-80. Review.

2.

Epidemiology of occupational asbestos-related diseases in China.

Cai SX, Zhang CH, Zhang X, Morinaga K.

Ind Health. 2001 Apr;39(2):75-83. Review.

3.

Health effects of asbestos exposure in humans: a quantitative assessment.

Boffetta P.

Med Lav. 1998 Nov-Dec;89(6):471-80. Review.

PMID:
10217936
4.

Chrysotile asbestos is the main cause of pleural mesothelioma.

Smith AH, Wright CC.

Am J Ind Med. 1996 Sep;30(3):252-66. Review.

PMID:
8876792
5.

Carcinogenicity of asbestos: convincing evidence, conflicting interests.

Chaturvedi S, Chaturvedi S.

Natl Med J India. 2001 Jan-Feb;14(1):43-6. Review.

PMID:
11242699
6.

The risk of mesothelioma from exposure to chrysotile asbestos.

Yarborough CM.

Curr Opin Pulm Med. 2007 Jul;13(4):334-8. Review.

PMID:
17534182
7.
8.

An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.

Gamble JF, Gibbs GW.

Regul Toxicol Pharmacol. 2008 Oct;52(1 Suppl):S154-86. doi: 10.1016/j.yrtph.2007.09.020. Epub 2007 Oct 22. Review.

PMID:
18396365
9.

The carcinogenicity of chrysotile asbestos--a review.

Nicholson WJ.

Ind Health. 2001 Apr;39(2):57-64. Review.

10.

Descriptive epidemiology of malignant mesothelioma.

Bertazzi PA.

Med Lav. 2005 Jul-Aug;96(4):287-303. Review.

PMID:
16457426
12.

An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.

Pierce JS, McKinley MA, Paustenbach DJ, Finley BL.

Crit Rev Toxicol. 2008;38(3):191-214. doi: 10.1080/10408440701845609. Review.

PMID:
18324516
13.

The epidemiology of asbestos-related diseases.

Niklinski J, Niklinska W, Chyczewska E, Laudanski J, Naumnik W, Chyczewski L, Pluygers E.

Lung Cancer. 2004 Aug;45 Suppl 1:S7-S15. Review.

PMID:
15261426
14.

Asbestos-related benign disease and cancer: symptoms and treatment.

Gruber UF.

Anticancer Drugs. 1990 Dec;1(2):187-97. Review.

PMID:
2151850
15.

The worldwide pandemic of asbestos-related diseases.

Stayner L, Welch LS, Lemen R.

Annu Rev Public Health. 2013;34:205-16. doi: 10.1146/annurev-publhealth-031811-124704. Epub 2013 Jan 4. Review.

PMID:
23297667
16.

The epidemiology of mesothelioma.

Britton M.

Semin Oncol. 2002 Feb;29(1):18-25. Review.

PMID:
11836665
17.

Mesothelioma and asbestos.

Gibbs GW, Berry G.

Regul Toxicol Pharmacol. 2008 Oct;52(1 Suppl):S223-31. Epub 2007 Oct 11. Review.

PMID:
18022298
18.

An overview of the risk of lung cancer in relation to exposure to asbestos and of taconite miners.

Berry G, Gibbs GW.

Regul Toxicol Pharmacol. 2008 Oct;52(1 Suppl):S218-22. Epub 2007 Oct 5. Review.

PMID:
17998152
19.

The carcinogenicity of chrysotile asbestos.

Harington JS.

Ann N Y Acad Sci. 1991 Dec 31;643:465-72. Review.

PMID:
1809160
20.

Carcinogenesis and related cell and tissue responses to asbestos: a review.

Mossman BT.

Ann Occup Hyg. 1994 Aug;38(4):617-24, 423. Review.

PMID:
7978984

Supplemental Content

Support Center